2JJS image
Entry Detail
PDB ID:
2JJS
Keywords:
Title:
Structure of human CD47 in complex with human signal regulatory protein (SIRP) alpha
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2008-04-22
Release Date:
2008-08-05
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.21
R-Value Work:
0.16
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1
Chain IDs:A, B
Chain Length:126
Number of Molecules:2
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Description:LEUKOCYTE SURFACE ANTIGEN CD47
Mutations:YES
Chain IDs:C, D
Chain Length:127
Number of Molecules:2
Biological Source:HOMO SAPIENS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN C ASN GLYCOSYLATION SITE
PCA C GLU PYROGLUTAMIC ACID
Primary Citation
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.
Mol. Cell 31 266 277 (2008)
PMID: 18657508 DOI: 10.1016/j.molcel.2008.05.026

Abstact

CD47 is a widely distributed cell-surface protein that acts a marker of self through interactions of myeloid and neural cells. We describe the high-resolution X-ray crystallographic structures of the immunoglobulin superfamily domain of CD47 alone and in complex with the N-terminal ligand-binding domain of signal regulatory protein alpha (SIRPalpha). The unusual and convoluted interacting face of CD47, comprising the N terminus and loops at the end of the domain, intercalates with the corresponding regions in SIRPalpha. We have also determined structures of the N-terminal domains of SIRPbeta, SIRPbeta(2), and SIRPgamma; proteins that are closely related to SIRPalpha but bind CD47 with negligible or reduced affinity. These results explain the specificity of CD47 for the SIRP family of paired receptors in atomic detail. Analysis of SIRPalpha polymorphisms suggests that these, as well as the activating SIRPs, may have evolved to counteract pathogen binding to the inhibitory SIRPalpha receptor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures